Primmus PDQ Plus fully automated glycoglobin analysis system - Taiwan Registration e3d3617905d5c93f0166c8767811e87f
Access comprehensive regulatory information for Primmus PDQ Plus fully automated glycoglobin analysis system in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number e3d3617905d5c93f0166c8767811e87f and manufactured by TRINITY BIOTECH PRIMUS CORPORATION DBA TRINITY BIOTECH. The authorized representative in Taiwan is PROGRESSIVE GROUP INC..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Product Details
High-pressure liquid chromatography was used as an in vitro diagnostic to quantify glycoglobin.
B Hematology, pathology, and genetics
B.7470 Analysis of glycosylated hemoglobin
import
Dates and Status
Feb 16, 2006
Feb 16, 2021
Sep 19, 2023
Cancellation Information
Logged out
่ช่ก้ตๅ ฅ